FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

West-Ward Pharmaceuticals Amoxicillin for Oral suspension Recall

Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only,…

West-Ward Pharmaceuticals Corp. · Eatontown, NJ

Risk level
Class III
Reported by FDA
Nov 30, 2016
Recall ID
D-0147-2017
Check your lot numberHow we source this data

Summary

West-Ward Pharmaceuticals recalled Amoxicillin for Oral suspension starting Nov 4, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0147-2017 on Nov 30, 2016. Reason: Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.

Product description

Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01

Lot numbers, UPCs & expiration codes

Lot #: AS1466A, Exp. Jan 2019

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0147-2017
Classification
Class III
Status
Terminated
Recall initiated
Nov 4, 2016
FDA report date
Nov 30, 2016
Quantity
32,102 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
West-Ward Pharmaceuticals Corp.

Original FDA data

Every field from FDA enforcement report D-0147-2017, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
75604
Address
401 Industrial Way West
Code information
Lot #: AS1466A, Exp. Jan 2019
Postal code
07724-2209
Report date
Nov 30, 2016
Product type
Drugs
Recall number
D-0147-2017
Classification
Class III
Recalling firm
West-Ward Pharmaceuticals Corp.
Product quantity
32,102 bottles
Termination date
Jun 16, 2017
Reason for recall
Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01
Distribution pattern
Nationwide
Recall initiation date
Nov 4, 2016
Initial firm notification
Letter
Center classification date
Nov 22, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0147-2017, published Nov 30, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls